Women living with HIV in Canada were found to have worse wellbeing when they had adversities related to social determinants ...

The proposal aims to align global leaders on pandemic prevention, preparedness, and response to future pandemics.

Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the ...

The executive order targets lower drug prices through Medicare reforms, anticompetitive crackdowns, and transparency mandates.

Systemic immune inflammation index, neutrophil-to-lymphocyte ratio, and systemic inflammation response index levels may offer ...

Erin Weber, MS, CAQH, is hopeful that artificial intelligence (AI) will empower people rather than replace them.

The electronic health record (EHR)–based symptom inventory identified symptom prevalence and associated comorbidities, but no ...

Progression-free survival improvement and drug costs make zanubrutinib a more cost-effective option in relapsed or refractory ...

JC Scott, CEO and president of The Pharmaceutical Care Management Association, discusses current efforts in increasing biosimilar adoption and pharmacy benefit manager (PBM) reform.

A new review finds federally qualified health centers (FQHCs) are underutilized in hypertension and type 2 diabetes clinical research, despite their potential to improve trial diversity.

Marla Black Morgan, MD, with Phoebe Neurology Associates, presented findings on a study into the diagnostic journey of patients with neuromuscular conditions who have rare diseases at the 2025 ...

Elizabeth Grush, MBA, speaks to the support, benefits, and holistic considerations that patient-centered care can provide for the betterment of patient experiences and outcomes.